By Owen Tucker-Smith
Becton Dickinson is expanding production of medical devices to meet demand from the U.S. health care system, the company said Wednesday.
The Franklin Lakes, N.J., company, which makes medical devices including syringes, diagnostic tests and surgical supplies, has already added new needle and syringe production lines at its plants in Connecticut and Nebraska. One of those lines is fully operational and others are set to start up in the coming months.
Overall, BD is expected to increase its production of domestically manufactured safety-engineered injection devices by more than 40% and conventional syringes by more than 50%. The manufacturer has hired over 215 staffers in Nebraska and Connecticut to support the effort.
In Utah, BD is set to spend over $30 million to boost its production of IV lines this year, after spending $2 million for IV line improvements last year.
BD runs more than 30 facilities across the U.S., employing over 10,000 people. It is expected to report earnings in February for its first quarter, with analysts expecting a profit of $865.6 million.
Write to Owen Tucker-Smith at owen.tucker-smith@wsj.com
(END) Dow Jones Newswires
January 15, 2025 07:50 ET (12:50 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。